VCYTbenzinga

Veracyte Updates FY22 Sales Guidance From $260M-$275M To $265M-$275M vs $270.3M Est.

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 3, 2022 by benzinga

    Veracyte Updates FY22 Sales Guidance From $260M-$275M To $265M-$275M vs $270.3M Est. | VCYT Stock News | Candlesense